Federal government to purchase additional 100 million doses of Johnson & Johnson’s COVID-19 vaccine
President Biden, citing the need for maximum flexibility in the nation’s vaccination program, today announced a deal for the U.S. government to purchase an additional 100 million doses of Johnson & Johnson’s single-shot COVID-19 vaccine.
Johnson & Johnson is working with Merck to increase supply, making such a deal possible.
The purchase doubles the nation’s projected supply of Johnson & Johnson doses, to 200 million. The intent of the purchase is to prepare for long-term supply needs, including the eventual vaccination of children and the possible need for booster shots to protect against COVID-19 variants.
Related News Articles
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…